Tenaya Therapeutics, Inc.
Price Action
Technical Summary
CONSOLIDATINGTenaya Therapeutics, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 32), showing significant lag compared to the market leaders. Earnings growth of 57% provides fundamental context to the price action. Investors should exercise caution due to high volatility (112% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.73 | +16.30% | ABOVE |
| 50 SMA | $0.74 | +15.33% | ABOVE |
| 100 SMA | $0.73 | +15.74% | ABOVE |
| 150 SMA | $0.99 | -14.66% | BELOW |
| 200 SMA | $1.02 | -17.07% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TNYA in an uptrend right now?
TNYA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is TNYA overbought or oversold?
TNYA's RSI (14) is 57. The stock is in neutral territory, neither overbought nor oversold.
Is TNYA outperforming the market?
TNYA has a Relative Strength (RS) Rating of 32 out of 99. TNYA is currently lagging the broader market.
Where is TNYA in its 52-week range?
TNYA is trading at $0.85, which is 36% of its 52-week high ($2.35) and 25% above its 52-week low ($0.36).
How volatile is TNYA?
TNYA has a Beta of 2.80 and 52-week volatility of 112%. It's more volatile than the S&P 500 - expect bigger swings.